Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of 2-{[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and 2-{benzyl[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and N-[2-(benzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride and N-[2-(dibenzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride and N-benzyl-2-{benzyl[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and N-benzyl-N-[2-(dibenzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride.
EC number: 700-961-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1993-03-04 to 1993-06-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (1987)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Version / remarks:
- (1984)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Reaction mass of 2-{[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and 2-{benzyl[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and N-[2-(benzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride and N-[2-(dibenzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride and N-benzyl-2-{benzyl[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and N-benzyl-N-[2-(dibenzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride.
- Molecular formula:
- Not applicable
- IUPAC Name:
- Reaction mass of 2-{[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and 2-{benzyl[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and N-[2-(benzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride and N-[2-(dibenzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride and N-benzyl-2-{benzyl[3-(trimethoxysilyl)propyl]amino}ethanaminium chloride and N-benzyl-N-[2-(dibenzylamino)ethyl]-3-(trimethoxysilyl)propan-1-aminium chloride.
- Test material form:
- liquid: viscous
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL Ltd., Basel, Switzerland
- Age at study initiation: approximately 7-12 weeks
- Weight at study initiation: males: 153-283 g, females: 134-233 g
- Fasting period before study: 18-25 hours prior to and 3-4 hours after dosing
- Housing: The animals were housed under stadard laboratory conditions. The animals were housed in groups of 5 per sex to a cage, using labelled polycarbonate cages containing purified sawdust as bedding material (Woody SPF, supplied by B.M.I., Someren, The Netherlands). Certificates of sawdust analysis were examined and then retained in the RCC NOTOX archives. The animals were identified by earmarks.
- Diet (ad libitum): standard pelleted laboratory animal diet (Kliba 343 from Klingentalmühle AG, Kaiseraugst, Switzerland). Certificates of analysis were examined and then retained in the RCC NOTOX archives.
- Water (ad libitum): tap-water. Certificates of analysis (performed quaterly) were examined and then retained in the RCC NOTOX archives.
- Acclimation period: at least 5 days before start of treatment under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 (fluctuations were noted, but were not considered to be relevant)
- Humidity (%): 55 (fluctuations were noted, but were not considered to be relevant)
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- paraffin oil
- Details on oral exposure:
- VEHICLE
- Specific gravity: 0.8
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg bw
DOSAGE PREPARATION
The prepared test substance was used within 80 minutes or 18 hours after preparation and the formulation was dosed within one hour after mixing. The prepared test substance was weighed into a dry glass flask on an analytical balance and the vehicle (w/w) was added. Adjustment was made for specific gravity of the vehicle. Homogeneity of the test substance was obtained by shaking and using a magnetic stirrer. Concentration of the test substance in vehicle was varied to allow constant dosage volume in terms of ml/kg body weight. - Doses:
- Group 1: 750 mg/kg bw
Group 2: 1250 mg/kg bw
Group 3: 1650 mg/kg bw
Group 4: 2000 mg/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations (mortality/viability): twice daily. The time of death was recorded as precisely as possible.
- Frequency of weighing: days 1 (pre-administration), 8, 15, and at death (if found dead after day 1)
- Frequency of observations (clinical signs): at periodic intervals on the day of dosing (day 1) and once daily thereafter. The time of onset, degree, and duration were recorded.
- Necropsy of survivors performed: yes (sacrifice by oxygen/carbon dioxide asphyxiation) - Statistics:
- No LD50 could be calculated due to mortality distribution.
Results and discussion
- Preliminary study:
- Initially a "Limit study" with the test material in paraffin oil at a dose level of 2000 mg/kg bw was performed. Due to the fact that all animals died, a "Pilot Study" was conducted in which three groups, each comprising of 1 male and 1 female rat were orally dosed with the test substance in paraffin oil at 50, 100, or 650 mg/kg bw. None of these animals died, only rough coat was observed in some animals. Therefore, two lower dose levels were selected for the full study and animals dosed at 1250 or 750 mg/kg bw. Due to the fact that no animals died, a fourth group was added and animals dosed at 1650 mg/kg bw. All animals receiving 1650 mg/kg bw died. No further groups were selected as a clear dose level at which animals died and at which animals survived (all within one classification group) was obtained.
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 1 250 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD100
- Effect level:
- 1 650 mg/kg bw
- Based on:
- test mat.
- Mortality:
- In groups 1 and 2 (750 and 1250 mg/kg bw) none of the animals (neither male nor female) died. In groups 3 and 4 (1650 and 2000 mg/kg bw) all animals (both males and females) died within 24 hours of dosing.
- Clinical signs:
- other: Group 1 (750 mg/kg bw): rough coat (1 male on day 10 only) Group 2 (1250 mg/kg bw): salivation (1 female on day 1 only) Group 3 (1650 mg/kg bw): no clinical signs observed Group 4 (2000 mg/kg bw): lethargy, clonic spasms, hunched posture, rough coat, wate
- Gross pathology:
- Group 1 (750 mg/kg bw): no abnormalities that were not commonly noted among rats of this strain and age
Group 2 (1250 mg/kg bw): no abnormalities that were not commonly noted among rats of this strain and age
Group 3 (1650 mg/kg bw): dark red focus/foci in the glandular stomach, haemorrhages in the wall of the duodenum, jejenum, and ileum, haemorrhages in the thymus
Group 4 (2000 mg/kg bw): dark red focus/foci in the glandular stomach, haemorrhages in the thymus, alopecia in the cervical region
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS Category 4 (H302) according to Regulation (EC) No 1272/2008
- Conclusions:
- The test item was tested for acute oral toxicity according to the OECD TG 401 (1987) and in compliance with GLP. The test item was found to be harmful as the experiment resulted in 1250 mg/kg bw < LD50 < 1650 mg/kg bw for both male and female rats. Hence, the substance has to be classified as acute oral toxicity Cat 4 according to EC/1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.